Phase I experience with rogaratinib in patients (pts) with urothelial carcinoma (UC) selected based on FGFR mRNA overexpression

Kempf, E; Penel, N; Tournigand, C; Gajate, P; Tan, DSW; Cassier, P; Nogova, L; Cathomas, R; Schostak, M; Janitzky, A; Wermke, M; Sayehli, C; Navarro, A; Park, SH; Piciu, AM; Bender, S; Nogai, H; Ellinghaus, P; Joerger, M; Schuler, MH

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (6):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索